Membrane microvesicles: Macromessengers in cancer disease and progression

Thrombosis Research

Volumn 125, Issue , 2010, Pages S84-S88

  Castellana, Donatello ^a,b,c   Toti, Florence ^a,b,c   Freyssinet, Jean Marie ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Biological messsengers; Haemostasis; Microparticles; Thrombosis; Tumour development

Indexed keywords

ANIMAL; DISEASE COURSE; HUMAN; MEMBRANE MICROPARTICLE; NEOPLASM; PATHOLOGY; REVIEW; THROMBOSIS;

ANIMALS; CELL-DERIVED MICROPARTICLES; DISEASE PROGRESSION; HUMANS; NEOPLASMS; THROMBOSIS;

EID: 77955488946     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70021-9     Document Type: Article

References (63)

1. Trousseau, A, Phlegmasia alba dolens, Clinique Medicale de l'Hotel-Dieu de Paris, 1865, J.B. Balliere et Fils, Paris, 654–712.
2. Donati, MB, Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. Thromb Haemost 74 (1995), 278–281.
3. Francis, JL, Biggerstaff, J, Amirkhosravi, A, Hemostasis and malignancy. Semin Thromb Hemost 24 (1998), 93–109.
4. Arkel, YS, Thrombosis and cancer. Semin Oncol 27 (2000), 362–374.
5. Rickles, FR, Falanga, A, Molecular basis for the relationship between thrombosis and cancer. Thromb Res 102 (2001), V215–V224.
6. Rickles, FR, Patierno, S, Fernandez, PM, Tissue factor, thrombin, and cancer. Chest 124:Suppl 3 (2003), 58S–68S.
7. Verso, M, Agnelli, G, Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21 (2003), 3665–3675.
8. Mackman, N, Tilley, RE, Key, NS, Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 27 (2007), 1687–1693.
9. Camerer, E, Gjernes, E, Wiiger, M, Pringle, S, Prydz, H, Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 275 (2000), 6580–6585.
10. Rickles, FR, Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol Haemost Thromb 35 (2006), 103–110.
11. Ruf, W, Redundant signaling of tissue factor and thrombin in cancer progression?. J Thromb Haemost 5 (2007), 1584–1587.
12. Peppelenbosch, MP, Versteeg, HH, Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med 11 (2001), 335–339.
13. Bassé, F, Gaffet, P, Rendu, F, Bienvenüe, A, Translocation of spin-labeled phospholipids through plasma membrane during thrombin- and ionophore A23187-induced platelet activation. Biochemistry 32 (1993), 2337–2344.
14. Zwaal, RF, Comfurius, P, Bevers, EM, Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. Biochem Soc Trans 21 (1993), 248–253.
15. Freyssinet, JM, Cellular microparticles: what are they bad or good for?. J Thromb Haemost 1 (2003), 1655–1662.
16. Freyssinet, JM, Toti, F, Membrane microparticle determination: at least seeing what's being sized. J Thromb Haemost, 2009 In Press.
17. Yuana, Y, Oosterkamp, TH, Bahatyrova, S, Ashcroft, B, Garcia Rodriguez, P, Bertina, RM, et al. Atomic force microscopy: a novel approach to detect nanosized blood microparticles. J Thromb Haemost, 2009 In Press.
18. Hugel, B, Martinez, MC, Kunzelmann, C, Freyssinet, JM, Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20 (2005), 22–27.
19. Morel, O, Toti, F, Hugel, B, Bakouboula, B, Camoin-Jau, L, Dignat-George, F, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 26 (2006), 2594–2604.
20. VanWijk, MJ, VanBavel, E, Sturk, A, Nieuwland, R, Microparticles in cardiovascular diseases. Cardiovasc Res 59 (2003), 277–287.
21. Ogura, H, Tanaka, H, Koh, T, Fujita, K, Fujimi, S, Nakamori, Y, et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J Trauma 56 (2004), 823–830.
22. Ginestra, A, La Placa, MD, Saladino, F, Cassará, D, Nagase, H, Vittorelli, ML, The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18 (1998), 3433–3437.
23. Kim, HK, Song, KS, Park, YS, Kang, YH, Lee, YJ, Lee, KR, et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastatic predictor. Eur J Cancer 39 (2003), 184–191.
24. Zwicker, JI, Liebman, HA, Neuberg, D, Lacroix, R, Bauer, KA, Furie, BA, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 15 (2009), 6830–6840.
25. Satta, N, Toti, F, Feugeas, O, Bohbot, A, Dachary-Prigent, J, Eschwége, V, et al. Monocyte vesiculation: A mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules following stimulation by lipopolysaccharide. J Immunol 153 (1994), 3245–3255.
26. Baron, JA, Gridley, G, Weiderpass, E, Nyren, O, Linet, M, Venous thromboembolism and cancer. Lancet 351 (1998), 1077–1080.
27. Ran, S, Thorpe, PE, Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys 54 (2002), 1479–1484.
28. Yu, JL, May, L, Lhotak, V, Shahrzad, S, Shirasawa, S, Weitz, JI, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105 (2005), 1734–1741.
29. Lacroix, R, Sabatier, F, Mialhe, A, Basire, A, Pannell, R, Borghi, H, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 110 (2007), 2432–2439.
30. Angelucci, A, D'Ascenzo, S, Festuccia, C, Gravina, GL, Bologna, M, Dolo, V, et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis 18 (2000), 163–170.
31. Zacharski, LR, Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy. Cancer Lett 186 (2002), 1–9.
32. Sudhoff, T, Schneider, W, Fibrinolytic mechanisms in tumor growth and spreading. Clin Investig 70 (1992), 631–636.
33. Costantini, V, Zacharski, LR, The role of fibrin in tumor metastasis. Cancer Metastasis Rev 11 (1992), 283–290.
34. Palumbo, JS, Kombrinck, KW, Drew, AF, Grimes, TS, Kiser, JH, Degen, JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96 (2000), 3302–3309.
35. Oberle, V, Fischer, A, Setzer, F, Lösche, W, Thrombus formation without platelets under inflammatory condition: an in vitro study. Platelets 18 (2007), 143–149.
36. Dvorak, FH, Rickles, FR, Malignancy and Hemostasis. Coleman, RB, Marder, VJ, Clowes, AW, George, JN, Goldhaber, SZ, (eds.) Hemostasis and thrombosis: basic principles and clinical practice, 5th ed., 2006, Lippincott Company Williams & Wilkins, Philadelphia, 851–873.
37. Rak, J, Yu, JL, Luyendyk, J, Mackman, N, Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 66 (2006), 10643–10646.
38. Hron, G, Kollars, M, Weber, H, et al. Tissue factor positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97 (2007), 119–123.
39. Tesselaar, ME, Romijn, FP, Van Der Linden, I, Prins, FA, Bertina, RM, Osanto, S, Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5 (2007), 520–527.
40. Milsom, C, Yu, J, May, L, Rak, J, Diverse roles of tissue factor-expressing cell subsets in tumor progression. Semin Thromb Hemost 34 (2008), 170–181.
41. Del Conde, I, Shrimpton, CN, Thiagarajan, P, López, JA, Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 (2005), 1604–1611.
42. Rauch, U, Antoniak, S, Tissue factor-positive microparticles in blood associated with coagulopathy in cancer. Thromb Haemost 97 (2007), 9–10.
43. Del Conde, I, Bharwani, LD, Dietzen, DJ, Pendurthi, U, Thiagarajan, P, López, JA, Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 5 (2007), 70–74.
44. Morrissey, JH, Pureza, V, Davis-Harrison, RL, Sligar, SG, Ohkubo, YZ, Tajkhorshid, E, Blood clotting reactions on nanoscale phospholipid bilayers. Thromb Res 122:Suppl 1 (2008), S23–S26.
45. Fernandes, RS, Kirszberg, C, Rumjanek, VM, Monteiro, RQ, On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells. J Thromb Haemost 4 (2006), 1546–1552.
46. Abid Hussein, MN, Böing, AN, Biró, E, et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res 121 (2008), 865–871.
47. Salzer, U, Hinterdorfer, P, Hunger, U, Borken, C, Prohaska, R, Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 99 (2002), 2569–2577.
48. Castellana, D, Zobairi, F, Martinez, MC, et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: A role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 69 (2009), 785–793.
49. Mallat, Z, Hugel, B, Ohan, J, Leséche, G, Freyssinet, JM, Tedgui, A, Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999), 348–353.
50. Morel, O, Morel, N, Freyssinet, JM, Toti, F, Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 19 (2008), 9–23.
51. Niemetz, J, Fallon, JT, Harrington, E, Hathcock, J, Rapid generation of thrombin by atheroma and platelets. J Thromb Haemost 2 (2004), 321–326.
52. Zwicker, JI, Furie, BC, Furie, B, Cancer-associated thrombosis. Crit Rev Oncol Hematol 62 (2007), 126–136.
53. Dvorak, HF, Senger, DR, Dvorak, AM, Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 2 (1983), 41–73.
54. Yu, J, May, L, Milsom, C, Anderson, GM, Weitz, JI, Luyendyk, JP, et al. Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol 28 (2008), 1975–1981.
55. Sidhu, SS, Mengistab, AT, Tauscher, AN, LaVail, J, Basbaum, C, The microvesicle as a vehicle for EMMPRIN in tumorstromal interactions. Oncogene 23 (2004), 956–963.
56. Miller, GJ, Bauer, KA, Howarth, DJ, Cooper, JA, Humphries, SE, Rosenberg, RD, Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost 2 (2004), 2107–2114.
57. Nierodzik, ML, Karpatkin, S, Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10 (2006), 355–362.
58. Kim, CW, Lee, HM, Lee, TH, Kang, C, Kleinman, HK, Gho, YS, Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 62 (2002), 6312–6317.
59. Milsom, C, Magnus, N, Meehan, B, Al-Nedawi, K, Garnier, D, Rak, J, Tissue Factor and Cancer Stem Cells Is There a Linkage?. Arterioscler Thromb Vasc Biol 29 (2009), 2005–2014.
60. Albanese, J, Meterissian, S, Kontogiannea, M, Dubreuil, C, Hand, A, Sorba, S, et al. Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles. Blood 91 (1998), 3862–3874.
61. O'Reilly, LA, Tai, L, Lee, L, Kruse, EA, Grabow, S, Fairlie, WD, et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 461 (2009), 659–663.
62. Lee, AY, Anticoagulation in the treatment of established venous thromboembolism in patients with cancer. J Clin Oncol 27 (2009), 4895–4901.
63. Miguet, L, Pacaud, K, Felden, C, Hugel, B, Martinez, MC, Freyssinet, JM, et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 6 (2006), 153–171.